%D8%A8%D9%8A%D8%B1%D9%8A%D9%85%D9%8A%D8%AB%D8%A7%D9%85%D9%8A%D9%86%D9%BE%DB%8C%D8%B1%DB%8C%D9%85%D8%AA%D8%A7%D9%85%DB%8C%D9%86PirimetaminaCategory:PyrimethaminePyrimethaminPyrimethaminPyrimethaminePirimetamina%D9%BE%DB%8C%D8%B1%DB%8C%D9%85%D8%AA%D8%A7%D9%85%DB%8C%D9%86PyrimetamiiniPyrim%C3%A9thaminePirimetaminPirimetamina%E3%83%94%E3%83%AA%E3%83%A1%E3%82%BF%E3%83%9F%E3%83%B3Pyrimethamine%E0%AC%AA%E0%AC%BE%E0%AC%87%E0%AC%B0%E0%AC%BF%E0%AC%AE%E0%AD%87%E0%AC%A5%E0%AC%BE%E0%AC%AE%E0%AC%BF%E0%AC%A8PirymetaminaPirimetaminaPirimetamin%C4%83PirimetaminPirimetamin%D0%9F%D1%96%D1%80%D1%96%D0%BC%D0%B5%D1%82%D0%B0%D0%BC%D1%96%D0%BDPyrimethamineQ421072%E4%B9%99%E8%83%BA%E5%98%A7%E5%95%B6
about
sameAs
P3781
Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-PyrimethamineAntimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria TransmissionRCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian InfantsArtesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax MalariaMulti-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum MalariaEfficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese ChildrenACT MALI: Treatment of Malaria Based on Combination TherapiesIPT of Malaria With SP in Different Zones of Drug Resistance in RwandaTo Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic RetinochoroiditisTreatment of Cerebral Toxoplasmosis in HIV/AIDSEvaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In AfricaPyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaClinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IRComparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating SchistosomiasisMass-Drug Administration to Reduce Malaria TransmissionIntermittent Preventive Treatment With Antimalarials in Kenyan InfantsAzithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaA Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African ChildrenChloroquine for Malaria in PregnancyPharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc)Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria (2003-01-31)Controlled Human Malaria Infection Transmission Model - Phase ASeasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension StudyOptimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
P4844
High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in TanzaniaSulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malariaChloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malariaSulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malariaRandomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study GroupEvolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparumAn open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGEEfficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina FasoMolecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in AfricaEfficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategiesResearch influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapyIntermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysisCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancyEvidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina FasoEfficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, ZambiaDeclining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern IndiaMolecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapyTreatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant allelesEmergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decadesPrevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-PyrimethamineDeclining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western EthiopiaThe effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in MalawiHigh-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in TanzaniaFrequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, YemenClinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionHigh efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studiesSustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytesLow-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, AngolaMolecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in TanzaniaDecreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndromePyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot studyPyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay SachsMegaloblastic anaemia associated with combined pyrimethamine and co-trimoxazole administrationSynergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosisInhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Pirimetamin
@id
Pirimetamin
@sh
Pirimetamin
@sr
Pirimetamina
@it
Pirimetamină
@ro
Pirymetamina
@pl
Pyrimetamiini
@fi
Pyrimethamin
@de
Pyrimethamine
@nl
Pyrimethamine
@vi
type
label
Pirimetamin
@id
Pirimetamin
@sh
Pirimetamin
@sr
Pirimetamina
@it
Pirimetamină
@ro
Pirymetamina
@pl
Pyrimetamiini
@fi
Pyrimethamin
@de
Pyrimethamine
@nl
Pyrimethamine
@vi
altLabel
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
@en
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
@en
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
@en
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
@en
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
@cy
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
@en
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
@en
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
@en
5-(4-klorofenil)-6-etil-2,4-pirimidindiamino
@eo
58-14-0
@fr
prefLabel
Pirimetamin
@id
Pirimetamin
@sh
Pirimetamin
@sr
Pirimetamina
@it
Pirimetamină
@ro
Pirymetamina
@pl
Pyrimetamiini
@fi
Pyrimethamin
@de
Pyrimethamine
@nl
Pyrimethamine
@vi